Compare
Dexcom vs Medtronic (DXCM vs MDT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Dexcom (DXCM) returned +34.0% and Medtronic (MDT) +12.6%; so far this year the figures are +19.6% and +6.0%.
Medtronic is the larger company by market value, about 4.4 times the size of Dexcom.
On trailing earnings, DXCM trades at 31.3 times and MDT at 25.0 times.
Revenue grew +13.0% at DXCM and +9.8% at MDT over the last year.
DXCM pays no dividend. MDT yields 2.81%.
Data as of the latest close. Not investment advice.
Relative performance
| DXCM | MDT | |
|---|---|---|
| Price | $79.41 | $101.80 |
| 1-day | -5.98% | -2.90% |
| YTD | +19.65% | +5.98% |
| 1 year | +33.96% | +12.61% |
| 3 years | -15.64% | +43.68% |
| Market cap | $29.6B | $130.2B |
| P/E | 31.3 | 25.0 |
| P/S | 5.80 | 3.47 |
| P/B | 11.68 | 2.59 |
| Revenue growth | +13.00% | +9.80% |
| EPS growth | +41.10% | +12.10% |
| Gross margin % | 63.4 | 65.0 |
| Net margin % | 19.4 | 13.9 |
| ROE % | 39.1 | 10.4 |
| Debt / equity | 0.00 | 0.56 |
| FCF yield % | 3.7 | 4.7 |
| Dividend yield % | — | 2.81 |
| Beta | 0.70 | 0.14 |
| RSI (14) | 42.8 | 63.8 |
| Technical rating |